Cary Street Partner Investment Advisory »

Mymd Pharmaceuticals shares owned by Cary Street Partner Investment Advisory

Quarter-by-quarter ownership of Mymd Pharmaceuticals shares owned by Cary Street Partner Investment Advisory from 13F filings

Historical chart of Cary Street Partner Investment Advisory investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Cary Street Partner Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Cary Street Partner Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7k 15k 0.26
2023-09-30 $8.6k 15k 0.59

More positions owned by Cary Street Partner Investment Advisory

Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Vanguard Value Etf Etf (VTV)
Vanguard Growth Etf Etf (VUG)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Msci Eafe Growth Etf Etf (EFG)
Amazon Stock (AMZN)
Jpmorgan Equity Premium Income Fund Jpmorgan Equity Premium Income Fund Etf (JEPI)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Total Stock Market Etf Etf (VTI)
Merck & Co Stock (MRK)
Adobe Stock (ADBE)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)

View all positions for Cary Street Partner Investment Advisory

Top funds holding Mymd Pharmaceuticals

Vanguard Group
Nwam
Millennium Management
Jane Street
Citadel Advisors
TCG Advisory Services
Parallel Advisors
Jpmorgan Chase & Co
HighTower Advisors
Advisor Group Holdings
Wells Fargo & Company
Sandy Spring Bank
Ancora Advisors
UBS Group
Royal Bank of Canada

View all funds holding Mymd Pharmaceuticals